Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-21

Clinical Trial Update: Effect of Oral Cimetidine in the Protoporphyrias [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oral cimetidine for erythropoietic protoporphyria and X-linked protoporphyria has completed, reporting results on its effect on disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cimetidine (CIMETIDINE)

Snippet

Sponsor: Amy K. Dickey, M.D. | Conditions: Erythropoietic Protoporphyria, X-linked Protoporphyria | Phase 2 | Status: COMPLETED